CN Patent

CN103814020B — 治疗活性组合物和它们的使用方法

Assigned to Agios Pharmaceuticals Inc · Expires 2017-07-14 · 9y expired

What this patent protects

提供了具有以下结构或(I)的化合物，其药学上可接受的盐，那些化合物用于治疗癌症的用途以及包括那些化合物的药物组合物。

USPTO Abstract

提供了具有以下结构或(I)的化合物，其药学上可接受的盐，那些化合物用于治疗癌症的用途以及包括那些化合物的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN103814020B
Jurisdiction
CN
Classification
—
Expires
2017-07-14
Drug substance claim
No
Drug product claim
No
Assignee
Agios Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.